Bacteria are useful targeted delivery agents and nanoparticles are efficient transporters of plasmid DNA. Now, a hybrid of the two will improve strategies to transfect cells for vaccination and cancer treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Akin, D. et al. Nature Nanotech. advance onine publication, 10 June 2007 (doi: 10.1038/nnano.2007.149).
Sizemore, D. R., Branstrom, A. A. & Sadoff, J. C. Science 270, 299–302 (1995).
Darji, A. et al. Cell 91, 765–775 (1997).
Dietrich, G. et al. Nature Biotechnol. 16, 181–185 (1998).
Niethammer, A. G. et al. Nature Med. 8, 1369–1375 (2002).
Souders, N. C., Verch, T. & Paterson, Y. DNA Cell Biol. 25, 142–151 (2006).
Xiang, S., Fruehauf, J. & Li, C. J. Nature Biotechnol. 24, 697–702 (2006).
Angelakopoulos, H. et al. Infect. Immun. 70, 3592–3601 (2002).
Gentschev, I. et al. Infect. Immun. 63, 4202–4205 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dietrich, G. Bacteria give nanoparticles a ride. Nature Nanotech 2, 394–395 (2007). https://doi.org/10.1038/nnano.2007.161
Published:
Issue Date:
DOI: https://doi.org/10.1038/nnano.2007.161
